| Financial Year |
March 31 2023 |
| Monetary Funds |
605,775,637.66 |
| Held-for-trading Financial Assets |
65,640,893.14 |
| Notes Receivable |
2,359,800.00 |
| Accounts Receivable |
519,344,475.88 |
| Advances to Suppliers |
236,522,816.87 |
| Other Receivables |
200,854,295.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
327,119,819.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,258,755.74 |
| Total Current Assets |
2,067,403,723.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,984,604.18 |
| Investment Properties |
4,713,940.33 |
| Fixed Assetes |
319,210,093.11 |
| Under-construction Projects |
34,390,939.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
137,764,836.42 |
| R&D expenses |
-- |
| Goodwill |
271,651,994.20 |
| Long-Term Deferred and Prepaid Expenses |
446,072.13 |
| Deferred Income Tax Assets |
20,853,369.02 |
| Other Non-Current Assets |
19,877,358.78 |
| Sub-Total of Non-Current Assets |
877,611,459.45 |
| Total Assets |
2,945,015,182.67 |
| Short-Term Loans |
101,027,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
91,657,248.40 |
| Accounts Payable |
266,624,186.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,205,933.28 |
| Taxes Payable |
9,703,703.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
378,937,686.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,312,156.02 |
| Other Current Liabilities |
27,398,722.11 |
| Sub-Total of Current Liabilities |
921,277,647.78 |
| Long-term Loans |
139,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,160,003.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
145,379,599.52 |
| Total Liabilities |
1,066,657,247.30 |
| Paid-In Capital(Or Share Stock) |
178,000,000.00 |
| Capital Surplus |
940,076,051.25 |
| Surplus Reserve |
20,707,867.02 |
| LESS:Treasury Stock |
173,400,000.00 |
| Undistributed Profits |
675,220,107.22 |
| Minority Stockholder's Interest |
229,802,466.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,648,555,469.10 |
| Owner's Equity（Stockholder's Equity） |
1,878,357,935.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,945,015,182.67 |
